14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 18, 2024 Buy 275 000 Waksal Harlan Common Stock
Mar 18, 2024 Buy 500 000 Palasis Maria Stock Option
Jan 30, 2024 Buy 200 000 Bishop John E Stock Options
Jan 30, 2024 Buy 200 000 Nieman Richard Stock Options
Jan 30, 2024 Buy 200 000 Cavalier Jason Stock Options
Nov 10, 2023 Buy 25 000 Waksal Harlan Common Stock
Jun 30, 2023 Buy 20 000 Tobin James R Stock Option
Jun 30, 2023 Buy 20 000 Smith W Bradford Stock Option
Jun 30, 2023 Buy 20 000 Poukalov Konstantin Stock Option
Jun 30, 2023 Buy 20 000 Altman Michael Seth Stock Option
Jun 30, 2023 Buy 20 000 Merrifield C Ann Stock Option
Jun 30, 2023 Buy 20 000 Anderson Edward T Stock Option
Jun 30, 2023 Buy 20 000 Snyderman Nancy Lynn Md Stock Option
Jun 15, 2023 Buy 150 000 Palasis Maria Stock Option
Jun 15, 2023 Buy 150 000 Palasis Maria Stock Option
May 31, 2023 Buy 1 203 612 Nbvm Gp, Llc Common Stock
May 31, 2023 Buy 403 858 Nbvm Gp, Llc Common Stock
May 31, 2023 Buy 197 946 Nbvm Gp, Llc Common Stock
May 31, 2023 Buy 601 806 Nbvm Gp, Llc Warrant to purchase Common Stock
May 31, 2023 Buy 201 929 Nbvm Gp, Llc Warrant to purchase Common Stock
May 31, 2023 Buy 98 973 Nbvm Gp, Llc Warrant to purchase Common Stock
May 31, 2023 Buy 1 203 612 Anderson Edward T Common Stock
May 31, 2023 Buy 403 858 Anderson Edward T Common Stock
May 31, 2023 Buy 197 946 Anderson Edward T Common Stock
May 31, 2023 Buy 601 806 Anderson Edward T Warrant to purchase Common Stock
May 31, 2023 Buy 201 929 Anderson Edward T Warrant to purchase Common Stock
May 31, 2023 Buy 98 973 Anderson Edward T Warrant to purchase Common Stock
May 31, 2023 Buy 3 610 832 Perceptive Advisors Llc Common Stock
May 31, 2023 Buy 1 805 416 Perceptive Advisors Llc Common Stock Purchase Warrant
Feb 27, 2023 Buy 220 000 Bishop John E Stock Option
Feb 27, 2023 Buy 0 Bishop John E
Jan 31, 2023 Buy 45 000 Richard Robert E. Stock Option
Jan 31, 2023 Buy 30 000 Richard Robert E. Common Stock
Jan 31, 2023 Buy 200 000 Waksal Harlan Stock Option
Jan 31, 2023 Buy 55 000 Noyes Corinne Stock Option
Jan 31, 2023 Buy 36 667 Noyes Corinne Common Stock
Jan 31, 2023 Buy 140 000 Cavalier Jason Stock Option
Jan 31, 2023 Buy 250 000 Palasis Maria Stock Option
Jan 31, 2023 Buy 55 537 Nieman Richard Stock Option
Jul 11, 2022 Buy 230 000 Nieman Richard Stock Option
Jul 11, 2022 Buy 0 Nieman Richard
Jun 16, 2022 Buy 7 250 Merrifield C Ann Stock Option
Jun 16, 2022 Buy 7 250 Merrifield C Ann Stock Option
Jun 16, 2022 Buy 7 250 Altman Michael Seth Stock Option
Jun 16, 2022 Buy 7 250 Altman Michael Seth Stock Option
Jun 16, 2022 Buy 7 250 Smith W Bradford Stock Option
Jun 16, 2022 Buy 7 250 Smith W Bradford Stock Option
Jun 16, 2022 Buy 7 250 Poukalov Konstantin Stock Option
Jun 16, 2022 Buy 953 002 Waksal Harlan Stock Option
Jun 16, 2022 Buy 953 002 Waksal Harlan Stock Option
Jun 16, 2022 Buy 7 250 Anderson Edward T Stock Option
Jun 16, 2022 Buy 7 250 Anderson Edward T Stock Option
Jun 16, 2022 Buy 7 250 Snyderman Nancy Lynn Md Stock Option
Jun 16, 2022 Buy 7 250 Snyderman Nancy Lynn Md Stock Option
Jun 10, 2022 Buy 4 000 Merrifield C Ann Common Stock
May 13, 2022 Buy 328 Merrifield C Ann Common Stock
May 13, 2022 Buy 3 500 Merrifield C Ann Common Stock
Apr 12, 2022 Buy 5 924 170 Edelman Joseph Common Stock
Apr 12, 2022 Buy 5 924 170 Perceptive Advisors Llc Common Stock
Apr 12, 2022 Buy 1 076 851 Nbvm Gp, Llc Common Stock
Apr 12, 2022 Buy 765 010 North Bridge Venture Management Vi, L.p. Common Stock
Apr 12, 2022 Buy 765 010 Nbvm Gp, Llc Common Stock
Apr 12, 2022 Buy 527 806 Nbvm Gp, Llc Common Stock
Apr 12, 2022 Buy 1 076 851 Anderson Edward T Common Stock
Apr 12, 2022 Buy 765 010 Anderson Edward T Common Stock
Apr 12, 2022 Buy 527 806 Anderson Edward T Common Stock
Apr 12, 2022 Buy 118 483 Anderson Edward T Common Stock
Apr 12, 2022 Buy 236 966 Waksal Harlan Common Stock
Mar 04, 2022 Buy 14 500 Tobin James R Stock Option
Mar 04, 2022 Buy 14 500 Tobin James R Stock Option
Mar 04, 2022 Buy 0 Tobin James R
Feb 16, 2022 Buy 175 000 Palasis Maria Stock Option
Feb 16, 2022 Buy 520 000 Waksal Harlan Stock Option
Feb 16, 2022 Buy 0 Waksal Harlan
Feb 12, 2022 Buy 32 000 Noyes Corinne Stock Option
Feb 12, 2022 Buy 127 400 Palasis Maria Stock Option
Feb 12, 2022 Buy 30 000 Nelson Pamela E. Stock Option
Feb 12, 2022 Buy 15 605 Cavalier Jason Stock Option
Feb 12, 2022 Buy 35 000 Richard Robert E. Stock Option
Sep 13, 2021 Buy 104 000 Cavalier Jason Stock Options (Right to Buy)
Sep 13, 2021 Buy 0 Cavalier Jason
Jun 17, 2021 Buy 3 500 Merrifield C Ann Common Stock
May 26, 2021 Buy 7 250 Altman Michael Seth Stock Option
May 26, 2021 Buy 7 250 Poukalov Konstantin Stock Option
May 26, 2021 Buy 7 250 Snyderman Nancy Lynn Md Stock Option
May 26, 2021 Buy 7 250 Merrifield C Ann Stock Option
May 26, 2021 Buy 7 250 Smith W Bradford Stock Option
May 26, 2021 Buy 7 250 Anderson Edward T Stock Option
Feb 08, 2021 Buy 45 000 Elsey R Don Stock Option
Feb 08, 2021 Buy 120 000 Palasis Maria Stock Option
Feb 08, 2021 Buy 30 000 Noyes Corinne Stock Option
Feb 08, 2021 Buy 13 000 Nelson Pamela E. Stock Option
Feb 08, 2021 Buy 18 000 Richard Robert E. Stock Option
Dec 16, 2020 Buy 1 025 Snyderman Nancy Lynn Md Common Stock
Oct 27, 2020 Buy 14 500 Snyderman Nancy Lynn Md Stock Option
Oct 27, 2020 Buy 0 Snyderman Nancy Lynn Md
Aug 03, 2020 Buy 35 000 Nelson Pamela E. Stock Option
Aug 03, 2020 Buy 0 Nelson Pamela E.
Jun 24, 2020 Buy 35 000 Richard Robert E. Stock Option
Jun 24, 2020 Buy 0 Richard Robert E.
INSIDER POWER
93.190
Last 100 transactions
Buy: 35 062 945 | Sell: 0 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 93.190.

In total, the insiders bought 35 062 945 and sold 0 LYRA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Lyra Therapeutics Inc.

Lyra Therapeutics. Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflam... LYRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT